Matthew P. Young
2016
In 2016, Matthew P. Young earned a total compensation of $2.8M as Executive Vice President and CFO at Jazz Pharmaceuticals, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $300,000 |
|---|---|
| Option Awards | $902,696 |
| Salary | $513,077 |
| Stock Awards | $1,110,239 |
| Other | $4,710 |
| Total | $2,830,722 |
Young received $1.1M in stock awards, accounting for 39% of the total pay in 2016.
Young also received $300K in non-equity incentive plan, $902.7K in option awards, $513.1K in salary and $4.7K in other compensation.
Rankings
In 2016, Matthew P. Young's compensation ranked 3,420th out of 14,075 executives tracked by ExecPay. In other words, Young earned more than 75.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,420 out of 14,075 | 76th |
Division Manufacturing | 1,192 out of 5,486 | 78th |
Major group Chemicals And Allied Products | 361 out of 1,900 | 81st |
Industry group Drugs | 262 out of 1,543 | 83rd |
Industry Pharmaceutical Preparations | 206 out of 1,173 | 82nd |
Source: SEC filing on June 20, 2017.
Young's colleagues
We found five more compensation records of executives who worked with Matthew P. Young at Jazz Pharmaceuticals in 2016.
2016
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2016
Russell Cox
Jazz Pharmaceuticals
Chief Operating Officer
2016
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2016
Karen Smith
Jazz Pharmaceuticals
Chief Marketing Officer
2016
Michael Miller
Jazz Pharmaceuticals